Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
American Journal of Surgery
|
February 1, 1975
Clinical spectrum of the Budd-Chiari syndrome and its surgical management
B Langer, R M Stone, R F Colapinto, et al.
Canadian Medical Association Journal
|
August 1, 1981
Caroli's disease: case report and management recommendations
L E Rotstein, L Makowka, J C Harvey, et al.
American Journal of Clinical Oncology
|
April 1, 1993
Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes
R M Stone, D R Spriggs, K A Arthur, et al.
Canadian Medical Association Journal
|
February 18, 1978
Selection of operation in patients with bleeding esophageal varices
B Langer, S C Patel, R M Stone, et al.
Blood
|
March 1, 1988
Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients
R M Stone, M Maguire, M A Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia
E H Rubin, J W Andersen, D T Berg, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 23, 2007
Torsades de pointes associated with voriconazole use
J A Philips, F M Marty, R M Stone, et al.
Leukemia
|
December 1, 1990
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia
R M Stone, D R Spriggs, R K Dhawan, et al.
Blood
|
January 15, 1994
All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line
K D Yang, T Mizobuchi, S M Kharbanda, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1992
Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors
K D Yang, R M Stone, C S Lee, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
American Journal of Surgery
|
February 1, 1975
Clinical spectrum of the Budd-Chiari syndrome and its surgical management
B Langer, R M Stone, R F Colapinto, et al.
Canadian Medical Association Journal
|
August 1, 1981
Caroli's disease: case report and management recommendations
L E Rotstein, L Makowka, J C Harvey, et al.
American Journal of Clinical Oncology
|
April 1, 1993
Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes
R M Stone, D R Spriggs, K A Arthur, et al.
Canadian Medical Association Journal
|
February 18, 1978
Selection of operation in patients with bleeding esophageal varices
B Langer, S C Patel, R M Stone, et al.
Blood
|
March 1, 1988
Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients
R M Stone, M Maguire, M A Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia
E H Rubin, J W Andersen, D T Berg, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
February 23, 2007
Torsades de pointes associated with voriconazole use
J A Philips, F M Marty, R M Stone, et al.
Leukemia
|
December 1, 1990
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia
R M Stone, D R Spriggs, R K Dhawan, et al.
Blood
|
January 15, 1994
All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line
K D Yang, T Mizobuchi, S M Kharbanda, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1992
Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors
K D Yang, R M Stone, C S Lee, et al.
Page
of 11